Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | Large Cap Stockholm |
Sektor | Hälsovård |
Industri | Vård & Omsorg |
Medicover AB (publ) ("Medicover (https://medicover-annualreport2021.creo.se/)") publishes the nomination committee's composition for the annual general meeting in 2023.
- Fredrik Stenmo, representing Celox Holding AB and the Christina af Jochnick family's total shareholding
- Hans Ramel, NG Invest Beta AB
- Jannis Kitsakis, Fjärde AP-Fonden
- Angelica Hanson, AMF och AMF Fonder
The Board of Medicover AB (publ)
For more information, please visit:medicover.com (https://www.medicover.com/financial-information/corporate-governance/nomination-committee)
Shareholders who wish to submit proposals to the nomination committee for the annual general meeting to be held on 27 April 2023 can do so by e-mail to nominationcommittee@medicover.comor:
Medicover AB
Att: Nomination Committee/General Legal Counsel
Box 5283, 102 46 Stockholm
Sweden
Proposals should be submitted to the nomination committee at latest on 9 March 2023.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities,laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2021, Medicover had revenue of EUR 1,377 million and more than 38,000 employees. For more information, go to www.medicover.com